Drug Approval | November 20, 2024
Lupin receives USFDA approval for mixed salts of a single-entity amphetamine ER capsules
The product will be manufactured at Lupin’s Somerset facility in the US
The product will be manufactured at Lupin’s Somerset facility in the US
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
This product will be manufactured at Lupin’s Nagpur facility in India
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
HYMPAVZI’s approval is based on Phase 3 study results demonstrating substantial bleed reduction compared to routine prophylaxis
The exclusive hospital will help address health complexities concerning women and children, specializing in high-end obstetrics, comprehensive gynecological, neonatal & pediatric care
Coal India has committed to providing upto Rs. 3 crore to treat thalassaemia and aplastic anaemia patients for a period of 3 years
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
The robotic surgery program has continually pushed the boundaries of medical technology
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
Subscribe To Our Newsletter & Stay Updated
